James P. Duffy
20, Route De Pré Bois
Geneve, GE 1215, Switzerland
Geneve, GE 1215, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Potent reaction hijacking inhibitors of Plasmodium falciparum asparagine tRNA synthetase.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026
Potent reaction hijacking inhibitors of Plasmodium falciparum asparagine tRNA synthetase.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026
Antiplasmodial Activity and Pharmacokinetic Profiling of Cryptolepine and 2,7-Dibromocryptolepine With a View to Informing the Design of Novel Antimalarial Cryptolepine Analogues.
Journal: Drug development research
Published: June 10, 2025
Optimization of Tambjamines Active against Multiple Stages of Malaria Parasites.
Journal: Journal of medicinal chemistry
Published: June 01, 2025
Cell-Based Progression of Spiroindoline Phenotypic Hits Leads to the Identification of Compounds with Diverging Parasitological Profiles against the Human Malaria Parasite Plasmodium falciparum.
Journal: Journal of medicinal chemistry
Published: May 12, 2025
Revisiting the Plasmodium falciparum druggable genome using predicted structures and data mining.
Journal: Research square
Published: December 09, 2024
Inhibitors of malaria parasite cyclic nucleotide phosphodiesterases block asexual blood-stage development and mosquito transmission.
Journal: Science advances
Published: December 06, 2024
Tambjamines as Fast-Acting Multistage Antimalarials.
Journal: ACS infectious diseases
Published: November 11, 2024
Revisiting the Plasmodium falciparum druggable genome using predicted structures and data mining.
Journal: NPJ drug discovery
Published: November 07, 2024
Dose-fractionation studies of a Plasmodium phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malaria.
Journal: Antimicrobial agents and chemotherapy
Published: August 28, 2024
Identification of mCMQ069, a novel antimalarial with potential for a single-dose cure and/or 28-day chemoprevention.
Journal: bioRxiv : the preprint server for biology
Published: July 15, 2024
A Prodrug Strategy to Reposition Atovaquone as a Long-Acting Injectable for Malaria Chemoprotection.
A Prodrug Strategy to Reposition Atovaquone as a Long-Acting Injectable for Malaria Chemoprotection.
Journal: bioRxiv : the preprint server for biology
Published: July 09, 2024
Last Updated: 09/26/2026